Department of Anesthesiology
[ Author(Desc)] Title Type Year
Filters: Keyword is Dogs  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Amar D, Heerdt PM, Korst RJ, Zhang H, Nguyen H.  2002.  The effects of advanced age on the incidence of supraventricular arrhythmias after pneumonectomy in dogs.. Anesth Analg. 94(5):1132-6,tableofcontents.
Antonio RP, Philbin DM, Savarese JJ.  1979.  Comparative haemodynamic effects of tubocurarine and metocurine in the dog.. Br J Anaesth. 51(11):1007-10.
B
Boyd RM, Nasjletti A, Heerdt PM, Baer PG.  1986.  PGI2 synthesis and excretion in dog kidney: evidence for renal PG compartmentalization.. Am J Physiol. 250(1 Pt 2):F58-65.
H
Heerdt PM, Wagner CL, DeMais M, Savarese JJ.  2011.  Noninvasive cardiac output monitoring with bioreactance as an alternative to invasive instrumentation for preclinical drug evaluation in beagles.. J Pharmacol Toxicol Methods. 64(2):111-8.
Heerdt PM, Caldwell RW.  1990.  The cardiovascular response to digoxin in conscious dogs with left atrial obstruction.. J Cardiothorac Anesth. 4(6):687-94.
Heerdt PM, Pond CG, Blessios GA, Rosenbloom M.  1992.  Comparison of cardiac output measured by intrapulmonary artery Doppler, thermodilution, and electromagnetometry.. Ann Thorac Surg. 54(5):959-66.
Heerdt PM, Kang R, The' A, Hashim M, Mook RJ, Savarese JJ.  2004.  Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs.. Anesthesiology. 100(4):846-51.
Heerdt PM, Gallagher JD, Caldwell RW.  1994.  Effect of halothane on in vivo and in vitro cardiotoxicity of an aminocardenolide.. J Cardiovasc Pharmacol. 23(6):890-6.
Heerdt PM, Blessios GA, Beach ML, Hogue CW.  2001.  Flow dependency of error in thermodilution measurement of cardiac output during acute tricuspid regurgitation.. J Cardiothorac Vasc Anesth. 15(2):183-7.
Heerdt PM, Malhotra JK, Pan BY, Sunaga H, Savarese JJ.  2010.  Pharmacodynamics and cardiopulmonary side effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs.. Anesthesiology. 112(4):910-6.
Heerdt PM, Caldwell RW.  1989.  The mechanism of nitrous oxide-induced changes in pulmonary vascular resistance in a dog model of left atrial outflow obstruction.. J Cardiothorac Anesth. 3(5):568-73.
L
Lien CA, Savard P, Belmont M, Sunaga H, Savarese JJ.  2009.  Fumarates: unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine.. J Crit Care. 24(1):50-7.
S
Savarese JJ, Ginsburg S, Lee SM, Kitz RJ.  1973.  The pharmacology of new short-acting nondepolarizing ester neuromuscular blocking agents: clinical implications.. Anesth Analg. 52(6):982-8.
Savarese JJ, Antonio RP, Ginsburg S.  1975.  Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments.. Anesth Analg. 54(5):669-78.
Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJJ.  2002.  Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome.. Ann Neurol. 51(5):634-7.
Sunaga H, Malhotra JK, Yoon E, Savarese JJ, Heerdt PM.  2010.  Cysteine reversal of the novel neuromuscular blocking drug CW002 in dogs: pharmacodynamics, acute cardiovascular effects, and preliminary toxicology.. Anesthesiology. 112(4):900-9.